Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Percutaneous Mitral Valve Therapy: The Next Decade

Executive Summary

After more than a decade, the field of transcatheter mitral valve therapy is still in its infancy, yet it is surprisingly crowded. The first percutaneous mitral valve company was founded in 1999, the same year that the first transcatheter aortic valve implantation (TAVI) company was founded, but while TAVI is now on the market in Europe and in the US, the leading transcatheter mitral valve therapy has only just completed clinical trials.


Related Content

Who’s Next? Ten Potential Medtech Takeover Targets
TAVR Competitors Put Pressure On Edwards To Deliver On New Growth Drivers
Middle Peak Medical: US Mitral Valve Start-Up Goes To Europe For Funding
Market & Industry Briefs
As TAVI Advances, Adjunctive Devices Multiply
Cardiac Rhythm Management Market Faces Continued Challenges Ahead
Percutaneous Heart Valve Technology: The Mitral Challenge
Evalve: Leading the Valve Revolution
Endovalve Inc.
ATI: Is This the Model for Device Development?


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts